BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25627761)

  • 1. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
    Ford CD; Lopansri BK; Haydoura S; Snow G; Dascomb KK; Asch J; Bo Petersen F; Burke JP
    Infect Control Hosp Epidemiol; 2015 Jan; 36(1):47-53. PubMed ID: 25627761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Snow GL; Webb BJ; Konopa KL; Petersen FB
    Transpl Infect Dis; 2015 Oct; 17(5):688-94. PubMed ID: 26256692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
    Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
    Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
    Ford CD; Gazdik Stofer MA; Coombs J; Lopansri BK; Webb BJ; Motyckova G; Petersen FB
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1055-1061. PubMed ID: 28724453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.
    Ford CD; Gazdik MA; Lopansri BK; Webb B; Mitchell B; Coombs J; Hoda D; Petersen FB
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):340-346. PubMed ID: 27890428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients.
    Sutcu M; Akturk H; Acar M; Salman N; Aydın D; Akgun Karapınar B; Ozdemir A; Cihan R; Citak A; Somer A
    Am J Infect Control; 2016 May; 44(5):515-9. PubMed ID: 26781220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):709-15. PubMed ID: 18631116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
    Song JY; Cheong HJ; Jo YM; Choi WS; Noh JY; Heo JY; Kim WJ
    Am J Infect Control; 2009 Nov; 37(9):734-40. PubMed ID: 19188004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
    Jung E; Byun S; Lee H; Moon SY; Lee H
    Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey.
    Goetz AM; Rihs JD; Wagener MM; Muder RR
    Am J Infect Control; 1998 Dec; 26(6):558-62. PubMed ID: 9836838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Webb B; Snow GL; Hoda D; Adams B; Petersen FB
    Am J Infect Control; 2016 Oct; 44(10):1110-1115. PubMed ID: 27287734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
    Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.